These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30662608)

  • 41. Downregulated Expression of Tropomyosin 1 in Intrahepatic Cholangiocarcinoma: A Predictor of Recurrence and Prognosis.
    Chen Y; Hong Z; Lu S; Zhang N; Rong G; Chang X; Liu Z; Bai W; Dong Z; Gao X; Zeng Z; Lu Y
    Med Sci Monit; 2018 Nov; 24():7875-7882. PubMed ID: 30390420
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Co‑expression of the carbamoyl‑phosphate synthase 1 gene and its long non‑coding RNA correlates with poor prognosis of patients with intrahepatic cholangiocarcinoma.
    Ma SL; Li AJ; Hu ZY; Shang FS; Wu MC
    Mol Med Rep; 2015 Dec; 12(6):7915-26. PubMed ID: 26499888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MiR-19b-3p facilitates the proliferation and epithelial-mesenchymal transition, and inhibits the apoptosis of intrahepatic cholangiocarcinoma by suppressing coiled-coil domain containing 6.
    Tang Y; Yang J; Wang Y; Tang Z; Liu S; Tang Y
    Arch Biochem Biophys; 2020 Jun; 686():108367. PubMed ID: 32315652
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TLR2 promotes human intrahepatic cholangiocarcinoma cell migration and invasion by modulating NF-κB pathway-mediated inflammatory responses.
    Liu B; Yan S; Jia Y; Ma J; Wu S; Xu Y; Shang M; Mao A
    FEBS J; 2016 Oct; 283(20):3839-3850. PubMed ID: 27616304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LKB1 inhibits intrahepatic cholangiocarcinoma by repressing the transcriptional activity of the immune checkpoint PD-L1.
    Liu Z; Li S; Zeng J; Zhou X; Li H; Liu X; Li F; Jiang B; Zhao M; Ma T
    Life Sci; 2020 Sep; 257():118068. PubMed ID: 32653521
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upregulated FFAR4 correlates with the epithelial-mesenchymal transition and an unfavorable prognosis in human cholangiocarcinoma.
    Meng FT; Huang M; Shao F; Huang Q
    Cancer Biomark; 2018; 23(3):353-361. PubMed ID: 30248044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer.
    Sakamoto K; Imai K; Higashi T; Taki K; Nakagawa S; Okabe H; Nitta H; Hayashi H; Chikamoto A; Ishiko T; Beppu T; Baba H
    Cancer Sci; 2015 Sep; 106(9):1153-62. PubMed ID: 26132727
    [TBL] [Abstract][Full Text] [Related]  

  • 48. KCa3.1 as an Effective Target for Inhibition of Growth and Progression of Intrahepatic Cholangiocarcinoma.
    Song P; Du Y; Song W; Chen H; Xuan Z; Zhao L; Chen J; Chen J; Guo D; Jin C; Zhao Y; Tuo B; Zheng S
    J Cancer; 2017; 8(9):1568-1578. PubMed ID: 28775776
    [No Abstract]   [Full Text] [Related]  

  • 49. Serum Nardilysin, a Surrogate Marker for Epithelial-Mesenchymal Transition, Predicts Prognosis of Intrahepatic Cholangiocarcinoma after Surgical Resection.
    Yoh T; Hatano E; Kasai Y; Fuji H; Nishi K; Toriguchi K; Sueoka H; Ohno M; Seo S; Iwaisako K; Taura K; Yamaguchi R; Kurokawa M; Fujimoto J; Kimura T; Uemoto S; Nishi E
    Clin Cancer Res; 2019 Jan; 25(2):619-628. PubMed ID: 30352908
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection.
    Huang C; Tian Y; Peng R; Zhang C; Wang D; Han S; Jiao C; Wang X; Zhang H; Wang Y; Li X
    J Gastroenterol Hepatol; 2015 Feb; 30(2):421-33. PubMed ID: 25168293
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathways.
    Chen XX; Yin Y; Cheng JW; Huang A; Hu B; Zhang X; Sun YF; Wang J; Wang YP; Ji Y; Qiu SJ; Fan J; Zhou J; Yang XR
    Cell Death Dis; 2018 Oct; 9(10):1036. PubMed ID: 30305612
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decreased expression of HDAC8 indicates poor prognosis in patients with intrahepatic cholangiocarcinoma.
    Zhu YJ; Xu Q; Shao MY; Cao XY; Wu ZR; Chen YW; Bu H; Shi YJ
    Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):464-470. PubMed ID: 31402267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MiR-590-3p suppresses epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma by inhibiting SIP1 expression.
    Zu C; Liu S; Cao W; Liu Z; Qiang H; Li Y; Cheng C; Ji L; Li J; Li J
    Oncotarget; 2017 May; 8(21):34698-34708. PubMed ID: 28423728
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of 5-hydroxymethylcytosine level in diagnosis and prognosis prediction of intrahepatic cholangiocarcinoma.
    Dong ZR; Zhang C; Cai JB; Zhang PF; Shi GM; Gao DM; Sun HC; Qiu SJ; Zhou J; Ke AW; Fan J
    Tumour Biol; 2015 Apr; 36(4):2763-71. PubMed ID: 25480415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic Nomogram Based on Histological Characteristics of Fibrotic Tumor Stroma in Patients Who Underwent Curative Resection for Intrahepatic Cholangiocarcinoma.
    Jing CY; Fu YP; Huang JL; Zhang MX; Yi Y; Gan W; Xu X; Shen HJ; Lin JJ; Zheng SS; Zhang J; Zhou J; Fan J; Ren ZG; Qiu SJ; Zhang BH
    Oncologist; 2018 Dec; 23(12):1482-1493. PubMed ID: 30257891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma.
    Park BK; Paik YH; Park JY; Park KH; Bang S; Park SW; Chung JB; Park YN; Song SY
    Am J Clin Oncol; 2006 Apr; 29(2):138-42. PubMed ID: 16601431
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 14-3-3σ downregulation suppresses ICC metastasis via impairing migration, invasion, and anoikis resistance of ICC cells.
    Yang Z; Jin Q; Hu W; Dai L; Xue Z; Man D; Zhou L; Xie H; Wu J; Zheng S
    Cancer Biomark; 2017 Jul; 19(3):313-325. PubMed ID: 28482619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long non-coding RNA UCA1 promotes proliferation and invasion of intrahepatic cholangiocarcinoma cells through targeting microRNA-122.
    Li O; Yi W; Yang P; Guo C; Peng C
    Exp Ther Med; 2019 Jul; 18(1):25-32. PubMed ID: 31258634
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway.
    Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P
    Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162
    [TBL] [Abstract][Full Text] [Related]  

  • 60. M3 muscarinic acetylcholine receptors regulate epithelial-mesenchymal transition, perineural invasion, and migration/metastasis in cholangiocarcinoma through the AKT pathway.
    Feng Y; Hu X; Liu G; Lu L; Zhao W; Shen F; Ma K; Sun C; Zhu C; Zhang B
    Cancer Cell Int; 2018; 18():173. PubMed ID: 30450012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.